Leuprolide Acetate Market By Mode of Administration (Subcutaneous and Intramuscular), Application (Uterine Fibroid, Precocious and Prostate Cancer) and End User (Clinics, Medical Institutes and Hospitals) - Global Industry Analysis And Forecast To 2025

Published On : August 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC081240

Industry Outlook

Leuprolide Acetate is an acetate salt produced using synthetic nonapeptide compound from gonadotropin-releasing hormone. Leuprolide Acetate forms a bond & activates gonadotropin-releasing hormone (GnRH) receptors. Leuprolide Acetateis used for medical applications like, treatment of prostate cancer, central precocious puberty, in vitro fertilization techniques and uterine fibroids. Leuprolide Acetate is also being tested for the use in treatment of Alzheimer’s disease, Leuprolide Acetate, polycystic ovary syndrome, premenstrual syndrome, short stature, etc. Use of Leuprolide Acetate is growing due to; rise in the aged population across the globe, rising investment, R&D in pharmaceutical & healthcare sectors, etc. Therefore, the Leuprolide Acetate Market is anticipated to expand and has tremendous scope during the forecast period. The global Leuprolide Acetate Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Leuprolide Acetate Market is based on segment, by Mode of Administration the market is segmented into Subcutaneous and Intramuscular, by Application the market is segmented into Uterine Fibroid, Precocious and Prostate Cancer, and by End User the market is segmented into Clinics, Medical Institutes and Hospitals.

  • Leuprolide Acetate Market, By Mode of Administration
  • Subcutaneous
  • Intramuscular
  • Leuprolide Acetate Market, By Application
  • Uterine Fibroid
  • Precocious
  • Prostate Cancer
  • Leuprolide Acetate Market, By End User
  • Clinics
  • Medical Institutes
  • Hospitals

Regional Insights

On a global front, the Leuprolide Acetate Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Leuprolide Acetate Market due to; increasing number of cases related to uterine fibroids & prostate cancer, increased expenditure on healthcare sector and highly developed healthcare sector.

Leuprolide Acetate Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Livzon Pharmaceutical Group Co. Ltd., Merck KGaA, TOLMAR Pharmaceuticals Inc., Abbott, Beijing Biote Pharmaceutical Co. Ltd., AbbVie Inc., Varian Pharmed, Sanofi, Avenit AG, Astellas Pharma, Soho-YImIng and Takeda Pharmaceutical Company Limited. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Livzon Pharmaceutical Group Co. Ltd.  
  • Merck KGaA
  • TOLMAR Pharmaceuticals Inc.
  • Abbott
  • Beijing Biote Pharmaceutical Co. Ltd.
  • AbbVie Inc. 
  • Varian Pharmed
  • Sanofi
  • Avenit AG
  • Astellas Pharma
  • Soho-YImIng
  • Takeda Pharmaceutical Company Limited

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Leuprolide Acetate Market, By Mode of Administration, Estimates and Forecast, 2014-2025 ($Million)

o   Subcutaneous

o   Intramuscular

o   Leuprolide Acetate Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

o   Uterine Fibroid

o   Precocious

o   Prostate Cancer

o   Leuprolide Acetate Market, By End User, Estimates and Forecast, 2014-2025 ($Million)

o   Clinics

o   Medical Institutes

o   Hospitals

Leuprolide Acetate Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Leuprolide Acetate Market, By Country

o   U.S. Leuprolide Acetate Market

o   Canada Leuprolide Acetate Market

o   Mexico Leuprolide Acetate Market

o   Europe

§  Europe Leuprolide Acetate Market, By Country

o   Germany Leuprolide Acetate Market

o   UK Leuprolide Acetate Market

o   France Leuprolide Acetate Market

o   Russia Leuprolide Acetate Market

o   Italy Leuprolide Acetate Market

o   Rest of Europe Leuprolide Acetate Market

o   Asia-Pacific

§  Asia-Pacific Leuprolide Acetate Market, By Country

o   China Leuprolide Acetate Market

o   Japan Leuprolide Acetate Market

o   South Korea  Leuprolide Acetate Market

o   India Leuprolide Acetate Market

o   Southeast Asia Leuprolide Acetate Market

o   Rest of Asia-Pacific Leuprolide Acetate Market

o   South America

§  South America Leuprolide Acetate Market, By Country

o   Brazil Leuprolide Acetate Market

o   Argentina Leuprolide Acetate Market

o   Columbia Leuprolide Acetate Market

o   Rest of South America Leuprolide Acetate Market

o   Middle East and Africa

§  Middle East and Africa Leuprolide Acetate Market, By Country

o   Saudi Arabia Leuprolide Acetate Market

o   UAE Leuprolide Acetate Market

o   Egypt Leuprolide Acetate Market

o   Nigeria Leuprolide Acetate Market

o   South Africa Leuprolide Acetate Market

o   Rest of MEA Leuprolide Acetate Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Leuprolide Acetate  Market, By Mode Of Administration

5.1.     Introduction

5.2.     Global Leuprolide Acetate  Revenue and Market Share by Mode Of Administration (2014-2018)

5.2.1.  Global Leuprolide Acetate  Revenue and Revenue Share by Mode Of Administration (2014-2018)

5.3.     Subcutaneous

5.3.1.  Global Subcutaneous Revenue and Growth Rate (2014-2018)

5.4.     Intramuscular

5.4.1.  Global Intramuscular Revenue and Growth Rate (2014-2018)

6.       Leuprolide Acetate  Market, By Application

6.1.     Introduction

6.2.     Global Leuprolide Acetate  Revenue and Market Share by Application (2014-2018)

6.2.1.  Global Leuprolide Acetate  Revenue and Revenue Share by Application (2014-2018)

6.3.     Uterine Fibroid

6.3.1.  Global Uterine Fibroid Revenue and Growth Rate (2014-2018)

6.4.     Precocious

6.4.1.  Global Precocious  Revenue and Growth Rate (2014-2018)

6.5.     Prostate Cancer

6.5.1.  Global Prostate Cancer  Revenue and Growth Rate (2014-2018)

7.       Leuprolide Acetate  Market, By End User

7.1.     Introduction

7.2.     Global Leuprolide Acetate  Revenue and Market Share by End User (2014-2018)

7.2.1.  Global Leuprolide Acetate  Revenue and Revenue Share by End User (2014-2018)

7.3.     Clinics

7.3.1.  Global Clinics  Revenue and Growth Rate (2014-2018)

7.4.     Medical Institutes

7.4.1.  Global Medical Institutes Revenue and Growth Rate (2014-2018)

7.5.     Hospitals

7.5.1.  Global Hospitals  Revenue and Growth Rate (2014-2018)

8.       Leuprolide Acetate  Market, By Region

8.1.     Introduction

8.2.     Global Leuprolide Acetate  Revenue and Market Share by Regions

8.2.1.  Global Leuprolide Acetate  Revenue by Regions (2014-2018)

8.3.     North America Leuprolide Acetate  by Countries

8.3.1.  North America Leuprolide Acetate  Revenue and Growth Rate (2014-2018)

8.3.2.  North America Leuprolide Acetate  Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Leuprolide Acetate  by Countries

8.4.1.  Europe Leuprolide Acetate  Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Leuprolide Acetate  Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Leuprolide Acetate  by Countries

8.5.1.  Asia-Pacific Leuprolide Acetate  Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Leuprolide Acetate  Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Leuprolide Acetate  by Countries

8.6.1.  South America Leuprolide Acetate  Revenue and Growth Rate (2014-2018)

8.6.2.  South America Leuprolide Acetate  Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Leuprolide Acetate  by Countries

8.7.1.  Middle East and Africa Leuprolide Acetate  Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Leuprolide Acetate  Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Sun Pharmaceutical Industries Ltd.

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Pfizer Inc.

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Livzon Pharmaceutical Group Co. Ltd. 

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Merck KGaA

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     TOLMAR Pharmaceuticals Inc.

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Abbott

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Beijing Biote Pharmaceutical Co. Ltd.

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     AbbVie Inc. 

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Varian Pharmed

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

9.10. Sanofi

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.       Revenue and Market Share

9.11. Avenit AG

9.11.1.      Business Overview

9.11.2.       Service Portfolio

9.11.3.      Strategic Developments

9.11.4.       Revenue and Market Share

9.12. Astellas Pharma

9.12.1.      Business Overview

9.12.2.       Service Portfolio

9.12.3.      Strategic Developments

9.12.4.       Revenue and Market Share

9.13. Soho-YImIng

9.13.1.      Business Overview

9.13.2.       Service Portfolio

9.13.3.      Strategic Developments

9.13.4.       Revenue and Market Share

9.14. Takeda Pharmaceutical Company Limited

9.14.1.      Business Overview

9.14.2.       Service Portfolio

9.14.3.      Strategic Developments

9.14.4.       Revenue and Market Share

10.    Global Leuprolide Acetate  Market Competition, by Manufacturer

10.1. Global Leuprolide Acetate  Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Leuprolide Acetate  Price By Region (2016-2017)

10.3. Top 5 Leuprolide Acetate  Manufacturer Market Share

10.4. Market Competition Trend

11.    Leuprolide Acetate  Market Forecast (2018-2025)

11.1. Global Leuprolide Acetate  Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Leuprolide Acetate  Market Forecast by Regions (2018-2025)

11.2.1.      North America Leuprolide Acetate  Market Forecast (2018-2025)

11.2.1.1. United States Leuprolide Acetate  Market Forecast (2018-2025)

11.2.1.2. Canada Leuprolide Acetate  Market Forecast (2018-2025)

11.2.1.3. Mexico Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.      Europe Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.1. Germany Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.2. France Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.3. UK Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.4. Russia Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.5. Italy Leuprolide Acetate  Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.      Asia-Pacific Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.1. China Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.2. Japan Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.3. Korea Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.4. India Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Leuprolide Acetate  Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Leuprolide Acetate  Market Forecast (2018-2025)

11.2.4.      South America Leuprolide Acetate  Market Forecast (2018-2025)

11.2.4.1. Brazil Leuprolide Acetate  Market Forecast (2018-2025)

11.2.4.2. Argentina Leuprolide Acetate  Market Forecast (2018-2025)

11.2.4.3. Columbia Leuprolide Acetate  Market Forecast (2018-2025)

11.2.4.4. Rest of South America Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.      Middle East and Africa Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.3. Egypt Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.4. Nigeria Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.5. South Africa Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.6. Turkey Leuprolide Acetate  Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Leuprolide Acetate  Market Forecast (2018-2025)

11.3. Leuprolide Acetate  Market Forecast by Mode Of Administration (2018-2025)

11.3.1.      Leuprolide Acetate  Forecast by Mode Of Administration (2018-2025)

11.3.2.      Leuprolide Acetate  Market Share Forecast by Mode Of Administration (2018-2025)

11.4. Leuprolide Acetate  Market Forecast by Application (2018-2025)

11.4.1.      Leuprolide Acetate  Forecast by Application (2018-2025)

11.4.2.      Leuprolide Acetate  Market Share Forecast by Application (2018-2025)

11.5. Leuprolide Acetate  Market Forecast by End User (2018-2025)

11.5.1.      Leuprolide Acetate  Forecast by End User (2018-2025)

11.5.2.      Leuprolide Acetate  Market Share Forecast by End User (2018-2025)


List of Tables

12. List of Tables and Figures
Figure United States Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Leuprolide Acetate Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Leuprolide Acetate Revenue and Revenue Share by Mode Of Administration (2014-2018)
Figure Global Subcutaneous Revenue and Growth Rate (2014-2018)
Figure Global Intramuscular Revenue and Growth Rate (2014-2018)
Table Global Leuprolide Acetate Revenue and Revenue Share by Application (2014-2018)
Figure Global Uterine Fibroid Revenue and Growth Rate (2014-2018)
Figure Global Precocious Revenue and Growth Rate (2014-2018)
Figure Global Prostate Cancer Revenue and Growth Rate (2014-2018)
Table Global Leuprolide Acetate Revenue and Revenue Share by End User (2014-2018)
Figure Global Clinics Revenue and Growth Rate (2014-2018)
Figure Global Medical Institutes Revenue and Growth Rate (2014-2018)
Figure Global Hospitals Revenue and Growth Rate (2014-2018)
Table Global Leuprolide Acetate Revenue by Regions (2014-2018)
Figure North America Leuprolide Acetate Growth Rate (2014-2018)
Figure North America Leuprolide Acetate Revenue and Growth Rate (2014-2018)
Figure North America Leuprolide Acetate by Countries (2014-2018)
Figure North America Leuprolide Acetate Revenue (Million USD) by Countries (2014-2018)
Figure United States Leuprolide Acetate Growth Rate (2014-2018)
Figure United States Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Leuprolide Acetate Growth Rate (2014-2018)
Figure Canada Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Leuprolide Acetate Growth Rate (2014-2018)
Figure Mexico Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Leuprolide Acetate Growth Rate (2014-2018)
Figure Europe Leuprolide Acetate Revenue and Growth Rate (2014-2018)
Figure Europe Leuprolide Acetate by Countries (2014-2018)
Figure Europe Leuprolide Acetate Revenue (Million USD) by Countries (2014-2018)
Figure Germany Leuprolide Acetate Growth Rate (2014-2018)
Figure Germany Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Leuprolide Acetate Growth Rate (2014-2018)
Figure France Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Leuprolide Acetate Growth Rate (2014-2018)
Figure UK Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Leuprolide Acetate Growth Rate (2014-2018)
Figure Russia Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Leuprolide Acetate Growth Rate (2014-2018)
Figure Italy Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Leuprolide Acetate Growth Rate (2014-2018)
Figure Rest of Europe Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Leuprolide Acetate Growth Rate (2014-2018)
Figure Asia-Pacific Leuprolide Acetate Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Leuprolide Acetate by Countries (2014-2018)
Figure Asia-Pacific Leuprolide Acetate Revenue (Million USD) by Countries (2014-2018)
Figure China Leuprolide Acetate Growth Rate (2014-2018)
Figure China Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Leuprolide Acetate Growth Rate (2014-2018)
Figure Japan Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Leuprolide Acetate Growth Rate (2014-2018)
Figure Korea Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Leuprolide Acetate Growth Rate (2014-2018)
Figure India Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Leuprolide Acetate Growth Rate (2014-2018)
Figure Southeast Asia Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Leuprolide Acetate Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Leuprolide Acetate Growth Rate (2014-2018)
Figure South America Leuprolide Acetate Revenue and Growth Rate (2014-2018)
Figure South America Leuprolide Acetate by Countries (2014-2018)
Figure South America Leuprolide Acetate Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Leuprolide Acetate Growth Rate (2014-2018)
Figure Brazil Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Leuprolide Acetate Growth Rate (2014-2018)
Figure Argentina Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Leuprolide Acetate Growth Rate (2014-2018)
Figure Columbia Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Leuprolide Acetate Growth Rate (2014-2018)
Figure Rest of South America Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Leuprolide Acetate Growth Rate (2014-2018)
Figure Middle East and Africa Leuprolide Acetate Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Leuprolide Acetate by Countries (2014-2018)
Figure Middle East and Africa Leuprolide Acetate Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Leuprolide Acetate Growth Rate (2014-2018)
Figure Saudi Arabia Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Leuprolide Acetate Growth Rate (2014-2018)
Figure United Arab Emirates Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Leuprolide Acetate Growth Rate (2014-2018)
Figure Egypt Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Leuprolide Acetate Growth Rate (2014-2018)
Figure Nigeria Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Leuprolide Acetate Growth Rate (2014-2018)
Figure South Africa Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Leuprolide Acetate Growth Rate (2014-2018)
Figure Turkey Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Leuprolide Acetate Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2014-2018)
Table Sun Pharmaceutical Industries Ltd. Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Livzon Pharmaceutical Group Co. Ltd. Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table TOLMAR Pharmaceuticals Inc. Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Beijing Biote Pharmaceutical Co. Ltd. Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Inc. Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Varian Pharmed Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avenit AG Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Soho-YImIng Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Company Limited Leuprolide Acetate Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Leuprolide Acetate Market Share by Manufacturer
Figure Global Leuprolide Acetate Revenue and Market Share by Manufacturer
Table Global Leuprolide Acetate Price by Region (2016-2017)
Figure Top 5 Leuprolide Acetate Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Leuprolide Acetate Revenue (Millions USD) and Growth Rate (2018-2025)
Table Leuprolide Acetate Market Forecast by Regions (2018-2025)
Figure North America Leuprolide Acetate Market Forecast (2018-2025)
Figure United States Leuprolide Acetate Market Forecast (2018-2025)
Figure Canada Leuprolide Acetate Market Forecast (2018-2025)
Figure Mexico Leuprolide Acetate Market Forecast (2018-2025)
Figure Europe Leuprolide Acetate Market Forecast (2018-2025)
Figure Germany Leuprolide Acetate Market Forecast (2018-2025)
Figure France Leuprolide Acetate Market Forecast (2018-2025)
Figure UK Leuprolide Acetate Market Forecast (2018-2025)
Figure Russia Leuprolide Acetate Market Forecast (2018-2025)
Figure Italy Leuprolide Acetate Market Forecast (2018-2025)
Figure Rest of Europe Leuprolide Acetate Market Forecast (2018-2025)
Figure Asia-Pacific Leuprolide Acetate Market Forecast (2018-2025)
Figure China Leuprolide Acetate Market Forecast (2018-2025)
Figure Japan Leuprolide Acetate Market Forecast (2018-2025)
Figure Korea Leuprolide Acetate Market Forecast (2018-2025)
Figure India Leuprolide Acetate Market Forecast (2018-2025)
Figure Southeast Asia Leuprolide Acetate Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Leuprolide Acetate Market Forecast (2018-2025)
Figure South America Leuprolide Acetate Market Forecast (2018-2025)
Figure Brazil Leuprolide Acetate Market Forecast (2018-2025)
Figure Argentina Leuprolide Acetate Market Forecast (2018-2025)
Figure Columbia Leuprolide Acetate Market Forecast (2018-2025)
Figure Rest of South America Leuprolide Acetate Market Forecast (2018-2025)
Figure Middle East and Africa Leuprolide Acetate Market Forecast (2018-2025)
Figure Saudi Arabia Leuprolide Acetate Market Forecast (2018-2025)
Figure United Arab Emirates Leuprolide Acetate Market Forecast (2018-2025)
Figure Egypt Leuprolide Acetate Market Forecast (2018-2025)
Figure Nigeria Leuprolide Acetate Market Forecast (2018-2025)
Figure South Africa Leuprolide Acetate Market Forecast (2018-2025)
Figure Turkey Leuprolide Acetate Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Leuprolide Acetate Market Forecast (2018-2025)
Figure Global Leuprolide Acetate Forecast by Mode Of Administration (2018-2025)
Figure Global Leuprolide Acetate Market Share Forecast by Mode Of Administration (2018-2025)
Figure Global Leuprolide Acetate Forecast by Mode Of Administration (2018-2025)
Figure Global Leuprolide Acetate Forecast by Application (2018-2025)
Figure Global Leuprolide Acetate Market Share Forecast by Application (2018-2025)
Figure Global Leuprolide Acetate Forecast by Application (2018-2025)
Figure Global Leuprolide Acetate Forecast by End User (2018-2025)
Figure Global Leuprolide Acetate Market Share Forecast by End User (2018-2025)
Figure Global Leuprolide Acetate Forecast by End User (2018-2025)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*